Farms.com Home   Ag Industry News

Researchers Develop Egg Sanitizing Machine

Researchers Develop Egg Sanitizing Machine

By Amanda Brodhagen, Farms.com

A new egg machine could revolutionize the poultry industry, saving poultry farmers thousands of eggs and dollars each year.

Texas A&M University researcher – Dr. Graig Coufal, created a machine that sanitizes eggs for hatching. Eggs are placed on a conveyor belt and then go through a sanitizing process. The eggs are sanitized by bringing together UV lights and hydrogen peroxide.

Currently, most farmers don’t clean their eggs, which leave them vulnerable to infection, as well as the potential for them to go rotten. While eggs are typically good at warding off bacteria 99% of the time, there are often on average 1% of eggs, which need to be discarded, which can affect a farmer’s bottom line, especially in a large facility.

Adopting an egg sanitizing machine, would address some production losses due to bacteria seeping into egg shells. Eggs that go through the process come out germ-free. The machine is currently being tested on a farm in East Texas. The cost of the machine is unknown.
 
 


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.